Honeywell International (HON) Earnings Analysis

Honeywell International (HON) reported results in line with expectations in FY2026 on revenue of $91.1B versus the $90.2B estimate (+1.5% YoY) and EPS of $2.42. Below is the full Honeywell International earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

Honeywell International (HON) Earnings Analysis — key stats

Next earnings dateJan 30, 2025
Latest reported quarterFY2026
Earnings verdictIn line
Revenue$91.1B (vs $90.2B est · +1.0% surprise · +1.5% YoY)
EPS$2.42 (vs $2.41 est · +0.4% surprise · -12.5% YoY)
Share price$421.32 (+1.0%)
Market cap$1.87T

What you'll find

Frequently asked questions

When is Honeywell International's next earnings date?
Honeywell International's (HON) next scheduled earnings date is Jan 30, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Honeywell International (HON) beat or miss earnings?
In FY2026, Honeywell International (HON) posted in-line results — revenue of $91.1B versus the $90.2B estimate (+1.0% surprise) and EPS of $2.42 versus $2.41 expected (+0.4% surprise). Magnisto decodes every Honeywell International (HON) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Honeywell International (HON) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Honeywell International (HON), anchored to the current $421.32 share price, so you can weigh the bull, base and bear cases for Honeywell International side by side.
Is Honeywell International (HON) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Honeywell International fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.